Skip to main content

Clinical Trials Using Cisplatin

Review the clinical trials studying cisplatin on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 176-200 of 202

Toripalimab, Gemcitabine, and Docetaxel before Chemoradiation for the Treatment of Locoregionally Advanced EBV Positive Nasopharyngeal Cancer
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Chemoradiotherapy followed by Chemotherapy and Dostarlimab for the Treatment of Stage IIIC Endometrial Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Adaptive Radiotherapy for the Treatment of Patients with Locally Advanced Anal Cancer
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Status: Active
Location: See ClinicalTrials.gov
Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
Status: Active
Location: See ClinicalTrials.gov
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Status: Active
Location: See ClinicalTrials.gov
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Status: Active
Location: See ClinicalTrials.gov
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Status: Active
Location: 4 locations
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Status: Active
Location: 2 locations
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Status: Active
Location: See ClinicalTrials.gov
Study of Novel Treatment Combinations in Patients With Lung Cancer
Status: Active
Location: See ClinicalTrials.gov
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
Status: Active
Location: See ClinicalTrials.gov
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
Status: Active
Location: See ClinicalTrials.gov
Telaglenastat and Chemoradiotherapy for the Treatment of Advanced Cervical Cancer
Status: Approved
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
A Cancer Vaccine (STEMVAC) in Combination with Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
Status: Approved
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Acetylcysteine for the Mitigation of Chemotherapy-Related Cognitive Impairment in Ovarian Cancer Patients Receiving Platinum-Based Therapy
Status: Approved
Location: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California
177Lu-PSMA-617 with Liver Directed Therapy for the Treatment of Castration Resistant Prostate Cancer with Liver Metastasis
Status: Approved
Location: University of California San Francisco, San Francisco, California
MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer
Status: Temporarily Closed to Accrual
Location: 3 locations
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined with Radiation for Patients with Advanced Head and Neck Cancer
Status: Temporarily Closed to Accrual
Location: 343 locations
Gemcitabine, Cisplatin, Quemliclustat and Zimberelimab for the Treatment of Patients with Advanced, Recurrent or Metastatic Biliary Tract Cancer
Status: Temporarily Closed to Accrual
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
New and Emerging Therapies for the treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Stereotactic Body Radiotherapy in Combination with Durvalumab, Cisplatin or Carboplatin, and Etoposide for Treatment of Refractory Extensive Stage Small Cell Lung Cancer
Status: Temporarily Closed to Accrual
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients with Head and Neck Cancer
Status: Active
Location: 143 locations
D-limonene, Radiation Therapy and Cisplatin for the Prevention of Xerostomia in Patients with Locally Advanced Head and Neck Squamous Cell Cancer
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California